Lessons from Recent Advances in Ischemic Stroke Management and Targeting Kv2.1 for Neuroprotection

Achieving neuroprotection in ischemic stroke patients has been a multidecade medical challenge. Numerous clinical trials were discontinued in futility and many were terminated in response to deleterious treatment effects. Recently, however, several positive reports have generated the much-needed exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Chung-Yang, Schulien, Anthony J., Molyneaux, Bradley J., Aizenman, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503403/
https://www.ncbi.nlm.nih.gov/pubmed/32854248
http://dx.doi.org/10.3390/ijms21176107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503403/
https://www.ncbi.nlm.nih.gov/pubmed/32854248
http://dx.doi.org/10.3390/ijms21176107

Ejemplares similares